Abstract
While the 131I diagnostic whole-body scans (DxWBS) is recommended for patients at high risk of recurrence and contraindicated for those at low-risk, its indication remains extremely controversial for patients at intermediate-risk. This is due to the possibility of a stunning effect and its lower sensitivity compared to the post-therapy WBS (RxWBS). Despite the benefits of identifying iod…